|
HS Code |
452763 |
| Compound Name | (E)-Ethyl 4-(3,4-Dimethoxyphenyl)-4-oxo-2-butenoate |
| Molecular Formula | C14H16O5 |
| Molecular Weight | 264.27 g/mol |
| Cas Number | 71902-23-9 |
| Appearance | Pale yellow to yellow solid |
| Smiles | CCOC(=O)C=CC(=O)C1=CC(=C(C=C1)OC)OC |
| Purity | Typically >98% |
| Melting Point | 87-89°C |
| Solubility | Soluble in organic solvents (e.g. DMSO, ethanol) |
| Storage Conditions | Store at 2-8°C, keep container tightly closed |
| Inchi | InChI=1S/C14H16O5/c1-3-19-14(17)7-6-13(15)10-4-5-11(16-2)12(8-10)18-9-13/h4-8H,3,9H2,1-2H3/b7-6+ |
| Synonyms | Ethyl (E)-4-oxo-4-(3,4-dimethoxyphenyl)-2-butenoate |
As an accredited (E)-Ethyl 4-(3,4-Dimethoxyphenyl)-4-Oxo-2-Butenoate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 25g of (E)-Ethyl 4-(3,4-Dimethoxyphenyl)-4-oxo-2-butenoate in a sealed amber glass bottle with tamper-evident cap and label. |
| Shipping | (E)-Ethyl 4-(3,4-Dimethoxyphenyl)-4-oxo-2-butenoate is shipped in a tightly sealed container, protected from light and moisture. The package is clearly labeled according to chemical safety regulations and may require a material safety data sheet (MSDS). Shipping complies with all relevant local and international hazardous material transport guidelines. |
| Storage | Store (E)-Ethyl 4-(3,4-dimethoxyphenyl)-4-oxo-2-butenoate in a tightly sealed container, protected from light and moisture. Keep at room temperature or as specified by the supplier, in a well-ventilated, cool, dry place away from incompatible substances such as strong oxidizers. Ensure storage area is secure and labeled, and follow standard laboratory chemical safety protocols. |
Applications of (E)-Ethyl 4-(3,4-Dimethoxyphenyl)-4-Oxo-2-Butenoate in Industrial ManufacturingAs a specialized manufacturer, we supply (E)-Ethyl 4-(3,4-Dimethoxyphenyl)-4-Oxo-2-Butenoate for downstream industries with established application fields and precise product demands. Below, we outline the primary areas where our material directly supports process innovation, regulatory compliance, and high-value end product output. 1. Pharmaceutical Intermediate for Anticancer API SynthesisThis compound serves as a key building block in the targeted synthesis of several API intermediates, particularly in the preparation of orally-administered anticancer molecules involving α,β-unsaturated carbonyl scaffolds. Pharmaceutical R&D teams employ this material in early-stage research and scale-up API process validation, strictly monitoring for process impurities and handling under ICH Q7 GMP systems. Usage volumes depend on the stoichiometry dictated by downstream synthetic routes and the specific target API scaffold. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Fine Chemical Precursor for Agrochemical SynthesisDownstream agrochemical formulators utilize this compound for constructing advanced intermediates found in selective herbicide and plant growth regulator products. Production adheres to local and export market standards on traceability and residue limits, especially where end-use applies to edible crop protection. Integration into pilot and commercial plant batches demands precise control over reaction kinetics and byproduct profiles. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Key Intermediate for Performance Dye and Pigment ManufacturingIn the colorant sector, this material enables the synthesis of high-performance dyes and pigments for use in textile, plastics, and specialty ink applications. Consistency in chromophore formation relies on the reproducibility of input chemical purity and blending methodology. Downstream manufacturers integrate the compound in controlled stepwise reactions to develop specific shade and fastness properties for premium end products. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Component in Electronic Chemical Formulations for OLED MaterialsProducers of organic electronic materials use this compound in the preparation of small molecule precursors for OLED emitters and charge transport materials. Electronic chemical manufacturers prioritize ultra-low trace metal and particulate levels, directing supply to cleanroom-controlled reaction environments. Ongoing process scale-up demands batch traceability and strong analytical support. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Intermediate for Development of Photoinitiators in UV Curing SystemsSpecialty chemical formulators employ this molecule to generate advanced aromatic structures for high-speed UV curing photoinitiators, supporting inks, coatings, and adhesives markets. Formulation engineers rely on its reactivity to introduce precise functional groups, controlling crosslinking rates in downstream UV systems. Applications require technical documentation for migration and safety in printing and packaging scenarios. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive (E)-Ethyl 4-(3,4-Dimethoxyphenyl)-4-Oxo-2-Butenoate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Years back, we noticed a steady increase in requests for (E)-Ethyl 4-(3,4-Dimethoxyphenyl)-4-Oxo-2-Butenoate. This molecule draws interest from researchers and industrial chemists alike. Right from the start, the complexity in the synthetic pathway brought a particular satisfaction—this compound’s structure challenges mass-production habits. Our process begins with sourcing dimethoxyphenyl intermediates of consistent purity, which means setting up a supply chain several steps upstream. In our facilities, the focus always lands on crystallinity, trace moisture, and the right temperature controls. Batch after batch, we monitor every step, knowing the finished product has to meet not just purity demands on paper, but also real-world chemical performance in downstream synthesis.
After years working these lines, I see certain patterns emerge. (E)-Ethyl 4-(3,4-Dimethoxyphenyl)-4-Oxo-2-Butenoate sits at a particular intersection in medicinal and advanced material pathways. Out of the reactions we run daily, the key step involves a Knoevenagel condensation—choose the catalyst wisely, and the process flows. Rush the reaction, and you’re left with side products that create headaches downstream. Our crew spent months dialing in the reaction time, optimizing solvent volumes, and handling byproduct removal from the mother liquor. Cleaning up isn’t glamorous work, but this is where quality happens.
We’ve never seen much point in hiding behind technical jargon or marketing fluff. When customers—mainly pharmaceutical researchers or specialty chemical teams—call asking about this compound, their questions always cut to performance details. They want crystallographic purity, low-level impurity profiles, and packing standards that hold up through international shipping. They want to know this material doesn’t degrade in storage, and that we’re not just relabeling a commodity batch. Since we invest in our own reactors and purification gear, we control every run from start to finish. It’s easy to spot a batch that doesn’t cut it. Long before delivery, our team pulls regular QC samples, checks for color, melting point, and chromatography signatures. Problems don’t slip past a well-trained crew.
We’ve settled on production runs that strike a balance between flexibility and output consistency. Too small, and costs creep up; too large, and the risk of process deviation becomes harder to manage. We tune vessel size and run frequencies to customer demand—often mid-scale, several kilo-batches at a time. Specifications in our shop center on purity levels typically measuring well above 98% by HPLC and GC. For a lot of our customers, this high bar isn’t just about paperwork: even a fraction of a percent impurity can create problems in advanced synthesis, especially where this compound serves as a key fragment in more complex molecules.
We package this compound in amber glass under inert atmosphere, knowing exposure to air and light can start slow degradation. Our warehouses stay cool and dry—no point in producing a careful batch only to ruin it with humidity. Over time, we’ve learned to avoid slip-ups during transfer and storage. Glass containers work better than most plastics for preventing any leaching or surface contact reactivity. With every batch, stability reports go into the record—these aren’t afterthoughts, they're part of our regular workflow.
Testing isn’t just for the client’s peace of mind. Fine control over moisture content makes a huge difference in product handling. If a chemist pulls a sample that clumps or cakes, trust erodes. Our team works batch-by-batch, running Karl Fischer titrations and thermogravimetric analysis. The results feed right back into process adjustments. Details matter: we monitor the hue, odor, and even the ‘feel’ in gloved hands. Years of manufacturing experience teach you the tell-tale signs that never show up in paperwork—off notes, slight discolorations, the way a powder pours.
Applications for (E)-Ethyl 4-(3,4-Dimethoxyphenyl)-4-Oxo-2-Butenoate keep expanding. We see it often as a precursor in pharmaceutical synthesis, especially in projects involving heterocyclic drug scaffolds and advanced intermediates. Medicinal chemists regularly tap it for coupling reactions aiming at various targeting agents, enzyme inhibitors, and possible anti-inflammatory candidates. Our production history tracks nearby the rise of research into small-molecule therapeutics. Academic labs sometimes approach us wanting small lots—grams or less—for screening work. Larger commercial partners lean on us for bulk production, scaling up for more serious formulation trials.
Beyond pharmaceuticals, this compound draws attention in advanced materials work. Organic electronics researchers, looking for new conjugated backbones, sometimes request custom derivatives or analogues. They need clean, well-characterized batches for reproducible device performance. Our conversations with their R&D teams often revolve around tweaking the ester or aryl substituents to fine-tune properties. Flexibility in synthesis allows us to pivot production based on these needs, since our setup runs on modular reactors and a semi-continuous system. Every time we scale a special order, our team revisits the parameters, so nothing slides by out of habit.
I keep hearing stories about traders in the supply chain who handle this molecule without knowing much about its temperament, or the real requirements of downstream chemists. Clients bring us tales of batches that look fine on one certificate of analysis but break down mid-experiment—a waste of money, time, and trust. Too many links in the chain, and quality gets diluted. We respond by keeping production in-house, only working with suppliers who clear our audits and can demonstrate the security of their supply. Our regular customers stick with us for that reason, and our technical support stays close—if a chemist hits a roadblock, they call us, not a faceless intermediary.
Talk with any synthetic chemist, and you’ll hear that (E)-Ethyl 4-(3,4-Dimethoxyphenyl)-4-Oxo-2-Butenoate doesn’t behave like off-the-shelf esters or vanilla chalcone derivatives. The dimethoxyphenyl group plays tricks on reactivity, and the (E)-configuration often makes a difference in downstream transformations—alpha, beta unsaturated esters have their quirks. In our experience, batches lacking strict control on stereoisomer purity quickly lead to problems, especially in asymmetric synthesis or stereospecific catalysis. Our process locks in the E-isomer, and we monitor this using both NMR and advanced chromatography.
Differences stand out in stability under normal lab storage. Some analogues lose punch due to trace peroxide formation or undergo slow rearrangement—those headaches cost weeks for any lab chasing scalable protocols. Our product, made with control at each step, resists degradation and keeps its sharp melting point. The methoxy substitutions on the aromatic ring require special handling during purification; they’re prone to demethylation if the process overheats. This means our operators check column temperatures, solvent strengths, and pressure ramps continuously. Skipping steps or ignoring details risks contamination, and this puts both research credibility and downstream process investments at risk.
Compare this to ethyl acetoacetate or methyl cinnamate: those are often run in commodity plants where bulk throughput trumps process nuance. Our approach sacrifices speed for reliability. We limit tolerance for off-spec runs and discard anything that doesn’t hit the numbers. The compound’s value comes from its clean transitions in multi-step syntheses. It’s not interchangeable with stock esters—we learned years ago that performance drops fast if attention to the precise structure slips.
The most complicated part of manufacturing this compound comes from upstream. Getting a consistent, high-quality (3,4-dimethoxy)phenyl source can feel like a juggling act. We put a lot of time into supplier screening and periodic qualification. Some years, price shocks or shortages ripple down, and small producers disappear overnight. Flexibility in logistics, combined with deep inventory holdings, lets us absorb surprises and keep production rolling.
Environmental and safety regulations change too. Solvent restrictions or pressure to swap out high-boiling chlorinated organics put stress on legacy processes. We’ve worked to replace older solvents and rearrange steps, balancing regulatory expectations with output quality. This sometimes eats into margins and slows throughput, but safety and sustainability trump shortcuts. We’ve switched part of our production line to greener solvents, pushing the boundaries of what works without feeding in off-odors or affecting crystal purity. Upgrades in vapor capture and filtration take effort but protect both workers and products. Storage containers remain ventilated and grounded, and regular air-quality checks back up our protocols.
Waste management deserves a mention. Synthetic chemistry isn’t a zero-footprint business, so capturing and neutralizing acidic or basic effluents takes daily attention. We treat outgoing streams on-site, rather than passing costs down the line. So far, this investment reduces incidents, avoids costly fines, and wins trust from long-term partners. That culture—of working the details and fixing problems before they leave the plant—shows in our product consistency. Each week brings a new challenge, but the rhythm of batch production, monitoring, and adjustment keeps things in check.
Once a batch leaves our plant, we still weigh responsibility for its performance. Technical teams in some customer labs call back with performance reports, or—rarely—issues needing fixes. Having made this compound so many times, we track the batch history, recheck retained samples, and answer with data, never speculation. If a problem ties back to raw materials, we trace the batch, test new lots, and sometimes revisit the supplier’s own manufacturing records. That open channel between operator, analytical chemist, and end user closes loops quickly. Over the years, that clarity supports science, rather than adding confusion or delay.
Handling requirements form part of every shipment, but we don’t just send out a standard leaflet. Our reports, built from real lab experience, outline best working temperatures, humidity thresholds, and packaging guidelines proven in hands-on transfer to glassware or reactors. Shelf-life, confirmed through long-term stability studies, features in our documentation—not as an estimate, but with hard numbers.
We coach clients on re-testing before major-scale synthesis. A sample stored outside of spec for weeks might behave unpredictably, so we back up those decisions with technical data and field experience. For R&D teams transitioning to pilot or commercial scale, we sometimes customize packaging or shipping routes, above what’s standard. Every delivery carries our company’s manufacturing fingerprint—a real stake in how the research or commercial process unfolds.
Our experience makes one thing clear: adaptability puts distance between a manufacturer and the risks of commoditization. Running deeper analytical checks, investing in process optimization, and staying close to customer feedback bring incremental changes, batch after batch. We’ve set up new reactor modules to allow for rapid scale-up or down based on demand, all without compromising the strict controls that set our product apart.
Speed counts, but quality sets reputations. Building a skilled team, recruiting chemists who know both bench science and process design, pays off. Our operators learn to spot issues before machines fail, or chemistry drifts. This expertise keeps false starts or off-spec product off the books. We also invest in cross-training—maintenance technicians join in analytical troubleshooting, and synthesis chemists rotate through QC work. This tight feedback loop brings fresh ideas and grows technical judgement.
Emerging requests for new analogues of (E)-Ethyl 4-(3,4-Dimethoxyphenyl)-4-Oxo-2-Butenoate—changing the ester tail, replacing aromatic substituents—push us to build out parallel synthesis options. We’re constantly reviewing literature and analyzing feedback from high-level customers to build new production sequences ready to run at laboratory or mid-scale, sometimes on short notice. Direct communication with end-users shapes our direction more than market reports ever will.
After years in this field, I’ve seen the strengths and setbacks of every production model. The direct-from-plant route matters most in specialty chemicals. We keep control of every variable, landing batches that don’t just pass regulatory muster but actually deliver in practice. Our real-world knowledge of the full process, product, and applications supports clients’ own technical success. Batch samples aren’t just paperwork—they’re a stake in another lab’s research and discovery path.
Taking full responsibility from sourcing to shipping, we aim to build a trust-based relationship. The work is never glamorous. It relies on the discipline of daily routines: solvent refilling, column watching, purity checks, and documentation. Genuine pride in a clean batch, a solid NMR readout, or a smooth customer hand-off—these are the moments our team values most. Each kilogram delivered stands as proof of our process and people.
(E)-Ethyl 4-(3,4-Dimethoxyphenyl)-4-Oxo-2-Butenoate doesn’t serve as just another chemical. For us, its production means investing in people, process, and an approach anchored in reliability. Our customers aren’t balancing cost alone; they stake their work, proposals, and progress on the material that heads out our doors. We work with that knowledge every day, lab shift by lab shift, adapting to new needs while never skipping the fundamentals. That’s what sets true manufacturers apart.